Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ioline D Henter

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|October 16, 2009
A role for PKC in mediating stress-induced prefrontal cortical structural plasticity and cognitive functionGuang Chen, Ioline D Henter, Husseini K Manji
Biological Psychiatry|May 12, 2010
Presynaptic glutamatergic dysfunction in bipolar disorderGuang Chen, Ioline D Henter, Husseini K Manji
Current Topics in Behavioral Neurosciences|September 20, 2014
Partial rodent genetic models for bipolar disorderGuang Chen, Ioline D Henter, Husseini K Manji
Biological Psychiatry|June 21, 2014
Looking ahead: electroretinographic anomalies, glycogen synthase kinase-3, and biomarkers for neuropsychiatric disordersGuang Chen, Ioline D Henter, Husseini K Manji
Drugs|June 27, 2012
Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to dateDaniel C Mathews, Ioline D Henter, Carlos A Zarate
Advances in Pharmacology (San Diego, Calif.)|February 8, 2018
Imaging Translocator Protein as a Biomarker of Neuroinflammation in DementiaWilliam C Kreisl, Ioline D Henter, Robert B Innis
Current Topics in Behavioral Neurosciences|September 20, 2014
Bipolar disorder: a neurobiological synthesisHusseini K Manji, Ioline D Henter, Carlos A Zarate
CNS Drugs|April 27, 2021
Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current StatusIoline D Henter, Lawrence T Park, Carlos A Zarate
Progress in Neurobiology|January 3, 2016
New targets for rapid antidepressant actionRodrigo Machado-Vieira, Ioline D Henter, Carlos A Zarate
CNS Drugs|January 11, 2022
Authors' Reply to Pappagallo et al.: Comment on "Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status"Ioline D Henter, Lawrence T Park, Carlos A Zarate
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Proceedings of the National Academy of Sciences of the United States of America|October 16, 2009
A role for PKC in mediating stress-induced prefrontal cortical structural plasticity and cognitive functionGuang Chen, Ioline D Henter, Husseini K Manji
Biological Psychiatry|May 12, 2010
Presynaptic glutamatergic dysfunction in bipolar disorderGuang Chen, Ioline D Henter, Husseini K Manji
Current Topics in Behavioral Neurosciences|September 20, 2014
Partial rodent genetic models for bipolar disorderGuang Chen, Ioline D Henter, Husseini K Manji
Biological Psychiatry|June 21, 2014
Looking ahead: electroretinographic anomalies, glycogen synthase kinase-3, and biomarkers for neuropsychiatric disordersGuang Chen, Ioline D Henter, Husseini K Manji
Drugs|June 27, 2012
Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to dateDaniel C Mathews, Ioline D Henter, Carlos A Zarate
Advances in Pharmacology (San Diego, Calif.)|February 8, 2018
Imaging Translocator Protein as a Biomarker of Neuroinflammation in DementiaWilliam C Kreisl, Ioline D Henter, Robert B Innis
Current Topics in Behavioral Neurosciences|September 20, 2014
Bipolar disorder: a neurobiological synthesisHusseini K Manji, Ioline D Henter, Carlos A Zarate
CNS Drugs|April 27, 2021
Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current StatusIoline D Henter, Lawrence T Park, Carlos A Zarate
Progress in Neurobiology|January 3, 2016
New targets for rapid antidepressant actionRodrigo Machado-Vieira, Ioline D Henter, Carlos A Zarate
CNS Drugs|January 11, 2022
Authors' Reply to Pappagallo et al.: Comment on "Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status"Ioline D Henter, Lawrence T Park, Carlos A Zarate
Pageof 8